No differences were observed in the proportion of carriers of MLH1, MSH2 and MSH6 gene mutations regarding gender, age at diagnosis, mean age at surgery and stage of first CRC between surgery groups (p > 0.5) (Table 1 and Table 3, Table S1). This evidence concerns the gene MSH6 and colorectal carcinoma.